^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Lyase inhibitor

    Related drugs:
    Apply
    Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR) (NCT01990209)
    Phase 2
    SCRI Development Innovations, LLC
    Completed
    Last update posted :
    06/30/2022
    Initiation :
    03/01/2014
    Primary completion :
    05/01/2021
    Completion :
    05/01/2021
    PGR
    |
    AR expression
    |
    orteronel (TAK 700)